Back to All Events

Dell Med CoLab - Funding For Your Health Startup

  • Health Discovery Building Room 1.204 1701 Trinity Street Austin, TX, 78705 United States (map)


Texas Health CoLab’s Monthly Learning Series - Convening to strengthen the health innovation pipeline

How do you to apply for an SBIR/STTR? Find out the details? You just learned that you won a what? Learn more about your grant administration responsibilities after you win the grant. Chris Laing, MRCVS, Ph.D., Executive Director of Capital City Innovation, and Yash Sabharwal, Ph.D., CEO of NanoMedical Systems and CherryCircle Software, will talk about applying for and managing SBIR/STTR grants.


Event Type: Free 

About the Speakers:

An accomplished entrepreneur, Yash Sabharwal has over 20 years of experience with establishing and growing technology-based companies in the life sciences. Yash co-founded his first company, Optical Insights, in 1997. In 2010, Yash joined the technical co-founders of Xeris Pharmaceuticals where he served as COO and CFO at from 2011 to 2016. Under his leadership and guidance, Xeris raised over $60M in private capital and $15M in non-dilutive funding. Yash is currently CEO of NanoMedical Systems, which he joined in the beginning of 2017 to help commercialize drug delivery and diagnostics products based on their proprietary nanochannel and nanoporous technologies. He is also a co-founder and CEO of CherryCircle Software, Inc. which develops cloud-based knowledge management solutions for lifecycle product management in pharmaceuticals and medical devices.

Yash has a B.S. in Optics from the University of Rochester and a M.S. and Ph.D. in Optical Sciences from the University of Arizona

As executive director of Capital City Innovation, Chris Laingleads an organization that is coordinating the stakeholders of the innovation district emerging around Austin’s new health complex. Chris serves on the Board of Directors of the South Jersey Technology Park, and the Oversight Committee for the FDA-funded Philadelphia Pediatric Device Consortium. Previously, Chris was a member of the senior management team of Philadelphia’s University City Science Center, the country’s oldest and largest urban innovation hub, where he had specific oversight of commercialization programs, startup investment, and business incubation/acceleration. Between 2010 and 2016, his portfolio companies collectively raised almost $600M in venture financing. Prior to joining the Science Center, Chris worked for a number of biomedical start-up companies, ran a research program at the University of Pennsylvania, and was a practicing companion animal veterinarian in the United Kingdom.

Chris completed his veterinary training and his PhD (in endocrinology) at the University of Sydney, and his post-doctoral training (in molecular biology) at the University of Pennsylvania’s School of Medicine.